e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
COPD: systemic inflammation and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Gender-specific differences in symptoms among patients with severe COPD
M. Cazzola, M. Miravitlles, C. Vogelmeier, M. Partridge, D. Leynaud, J. Ostinelli, R. Kessler (Rome, Italy; Barcelona, Spain; Marburg, Germany; London, United Kingdom; Rueil-Malmaison, Strasbourg, France)
Source:
Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Session:
COPD: systemic inflammation and comorbidities
Session type:
Thematic Poster Session
Number:
569
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Cazzola, M. Miravitlles, C. Vogelmeier, M. Partridge, D. Leynaud, J. Ostinelli, R. Kessler (Rome, Italy; Barcelona, Spain; Marburg, Germany; London, United Kingdom; Rueil-Malmaison, Strasbourg, France). Gender-specific differences in symptoms among patients with severe COPD. Eur Respir J 2010; 36: Suppl. 54, 569
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
Gender differences in hospitalised COPD patients
Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD
Year: 2010
Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
What are the differences between moderate and severe COPD exacerbation groups?
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Clinical phenotypic differences between COPD and asthma in elderly patients
Source: Eur Respir J 2004; 24: Suppl. 48, 60s
Year: 2004
Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021
Gender differences in exertional breathlessness in patients with mild COPD
Source: Annual Congress 2007 - Advances in respiratory muscles
Year: 2007
Gender differences in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Gender differences of echocardiographic characteristics in patients with acute exacerbation of COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Relationship between pharmacotherapy and severity of disease in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 73s
Year: 2007
Cardiovascular comorbidity in severe COPD patients
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Relationship of anxiety and depression with sociodemographic characteristics in hospitalized patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018
GERD and anxiety in patients with severe COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Predictors of severe exacerbations in patients with moderate and severe asthma
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Characterising symptom ‘trajectotypes’ in patients with COPD
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Markers of T2-inflammation in patients with severe asthma and concomitant COPD
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Prevalence of comorbidities in patients with COPD in south-Spain
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Drivers of respiratory symptoms in COPD patients
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018
Are comorbidities related to frequent severe exacerbations of COPD?
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept